New research in The FASEB Journal suggests that an abnormal amount of an inflammatory protein called PAR2 is present on abdominal fat tissues of overweight and obese humans and rats
Scientists have moved a step closer to an “obesity drug” that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that there is an abnormal amount of an inflammatory protein called PAR2 in the abdominal fat tissue of overweight and obese humans and rats. This protein is also increased on the surfaces of human immune cells by common fatty acids in the diet. When obese rats on a diet high in sugar and fat were given a new oral drug that binds to PAR2, the inflammation-causing properties of this protein were blocked, as were other effects of the high-fat and high-sugar diet–including obesity itself.
“This important new finding links obesity and high fat high sugar diets with changes in immune cells and inflammatory status, highlighting an emerging realization that obesity is an inflammatory disease,” said David P. Fairlie, Ph.D., study author from the Institute for Molecular Bioscience at the University of Queensland, in Bribane, Australia. “Drugs designed to block certain inflammatory proteins, as in this report, may be able to prevent and treat obesity, which in turn is a major risk factor for type 2 diabetes, heart disease, stroke, kidney failure, limb amputation, and cancers.”
To make this discovery, Fairlie and colleagues discovered the first potent, selective and orally bioavailable small molecule antagonists of PAR2 and characterized their functional responses in inflammatory cellular and animal models. They found that PAR2 expression is increased in vivo in adipose tissue from obese humans and rats, stimulated in vitro in human macrophages by the dietary fatty acid palmitic acid, and inhibited in vivo and in vitro by a PAR2 antagonist. This antagonist was then used as a tool to dissect roles for PAR2 activation in mediating metabolic dysfunction in human monocyte-derived macrophages (HMDM), human and rodent adipocytes, and diet-induced obesity in rats. Oral treatment of diet-induced obese rats attenuated PAR2 signaling in adipose tissue and inhibited adipose inflammation, insulin resistance, diet-induced obesity and cardiovascular abnormalities. This is the first report that a PAR2 antagonist improves obesity, glucose homeostasis and obesity-associated chronic inflammation in vivo. These findings indicate that increased PAR2 expression may be a valuable new biomarker for metabolic dysfunction and further, that PAR2 antagonism can be an effective intervention for treating metabolic dysfunction and obesity.
“We know that that eating too much and not exercising enough makes you overweight, and then obese, but why? The bottom line of this report is that obesity is an inflammatory disease, and inflammation plays a greater role in the downward spiral to obesity than most people realize.” said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. “It appears that once we can control the inflammation, we can begin to get everything else in line. Fortunately, these scientists have already identified one promising compound that seems to work.”
The Latest on: Obesity is an inflammatory disease
- AHA News: Obesity Harms Brain Health Throughout Life – Yet Scientists Don't Know Whyon January 13, 2022 at 6:16 am
Research shows obesity impacts brain health from childhood well into adulthood, affecting everything from executive function skills – the complex ability to initiate, plan and carry out tasks – to ...
- Obesity harms brain health throughout life, yet scientists don't know whyon January 13, 2022 at 5:21 am
Anyone who has put on a few too many pounds knows they can slow you down. Over time, if those pounds grow into obesity, they may do serious harm, putting you at risk for a wide range of illnesses.
- The worst pandemic facing America right now isn't COVID-19. It's obesity. Why that matterson January 13, 2022 at 2:07 am
Obesity is linked to many chronic diseases, including cancers, Type 2 diabetes and COVID-19, and is a major health problem that should not be ignored.
- Animal Study Suggests Link Between Obesity and Gum Diseaseon December 20, 2021 at 3:58 pm
Kirkwood said the findings may also provide new insight into the mechanisms of other chronic inflammatory, bone-related diseases that can accompany obesity, such as arthritis and osteoporosis.
via Bing News
The Latest on: Inflammatory disease
- Evelo Biosciences Presents Data on EDP1815 Mechanism of Action and Supporting Ongoing Clinical Development for Inflammatory Diseaseson January 17, 2022 at 4:06 am
Evelo Biosciences Presents Data on EDP1815 Mechanism of Action and Supporting Ongoing Clinical Development for Inflammatory Diseases ...
- Multiple sclerosis may be caused by common ‘kissing disease’ virus: scientistson January 14, 2022 at 11:21 am
A virus that infects more than 90% of adults and causes the “kissing disease,” or mono, has been linked with the onset of multiple sclerosis in a new study.
- Top in rheumatology: Inflammatory disease biosimilars, depression in patients with lupuson January 14, 2022 at 8:29 am
Boehringer Ingelheim’s Cyltezo was approved by the FDA as the first interchangeable biosimilar to AbbVie’s Humira.
- Promising new treatment for dry eye diseaseon January 13, 2022 at 9:36 am
The University of Manchester, Seoul National University College of Medicine and Link Biologics Limited today announced that promising preclinical data on the treatment of dry eye disease using a novel ...
- Rare Inflammatory Disease Treatment Market Trends and Forecaston January 12, 2022 at 7:40 pm
Rare Inflammatory Disease Treatment Market is expected to value over USD xx billion by 2027 end and register a CAGR of 4.3% from the forecast period ...
- Alzheimer’s: Inflammatory markers are conspicuous at an early stageon January 12, 2022 at 11:38 am
Long before the onset of dementia, there is evidence for increased activity of the brain's immune system. Researchers from DZNE and the University Hospital Bonn (UKB) come to this conclusion based on ...
- Uncovering cellular mechanisms of genetic skin diseaseson January 12, 2022 at 5:16 am
Northwestern Medicine investigators have discovered a novel mechanism linking an intercellular adhesion molecule with genetic inflammatory skin diseases, according to findings published in the Journal ...
- Crohn’s disease: Groundbreaking research implies link to the inflammatory conditionon January 11, 2022 at 11:58 am
CROHN'S disease is a chronic inflammatory bowel condition where areas of your digestive system can become inflamed. You might know or be aware of Crohn's disease, but less familiar with the causes.
- Research may lead to new treatment options for Crohn's disease patientson January 10, 2022 at 4:06 pm
Results of a new study by researchers at Case Western Reserve University represent a step toward improving our understanding of Crohn's disease and the factors that cause its intestinal inflammation.
- Spike in autoimmune diseases blamed on fast food: scientistson January 10, 2022 at 11:09 am
Asia and the Middle East have seen the biggest upswing in inflammatory bowel disease — these regions have experienced a boom of the fast food industry during that time.
via Bing News